Top five mid-cap stocks that reported better than expected Q2 resultsIndia Inc. might be showing signs of slowdown, however, a large number of companies are beating analysts' estimates this earnings season.
17 Nov, 2012, 12.29 PM IST
- Biocon's drug development partner Optimer receives US patent for Fidaxomicin
The closest competitor for Fidaxomicin is vancomycin - an antibiotec injectable manufactured and supplied by Strides Arcolabs.
18 Mar, 2011, 03.52 AM IST
- Stocks to watch: Godrej Consumer, Tata Chemicals, Aban Offshore, Mahindra Satyam, Lupin, Biocon, Tata Power
The Godrej Group has consolidated the operations of insecticides joint venture Godrej Sara Lee with Godrej Consumer Products in a bid to ta...
25 May, 2010, 09.40 AM IST